The 2026 Healthtech Messaging Index

Rank#202of 302

Vivalink

vivalink.com·scored November 1, 2026

45out of 100

17/38

Invisible

The page is doing some work, but the story isn't landing fast enough. Buyers and AI are both left guessing what makes Vivalink different.

InvisibleAI recommends them? Yes
Vivalink homepage

The page we scored

The AI Recommendation Check

When we asked AI who to recommend for medical wearables and remote patient monitoring platform for clinical trials and digital health, it named:

Buyer we put in the prompt: Clinical Operations Director or VP of Digital Health at a pharmaceutical company, CRO, or health system running decentralized clinical trials or remote patient monitoring programs. Both the buyer and the category were inferred from Vivalink’s homepage alone. The model had no web access.

MedtronicBiofourmisBioIntelliSenseVerilyiRhythmCurrent HealthPhilips

Vivalink was on the list.

AI named them for their own category. That's the signal every homepage is supposed to send.

AI named you when asked who it recommends for "medical wearables and remote patient monitoring platform for clinical trials and digital health", and described you accurately: "Vivalink offers a suite of medical-grade wearable biosensors and a cloud-based data platform designed for remote patient monitoring in clinical trials and decentralized study environments.". Your positioning is landing with the machines.

Overall assessment

Vivalink's biggest strength is its logo wall ... AstraZeneca, Novartis, Lilly, Stanford, IQVIA ... which instantly signals enterprise credibility in a trust-dependent category. The biggest gap is a near-total absence of stakes, outcomes, and differentiation: the page never tells a buyer what it costs to do nothing, never shows a before/after result, and never makes a case why Vivalink beats the status quo, leaving the narrative too thin to convert a skeptical buyer or earn an AI recommendation.

Signal by category

Narrative Clarity

8 signals

6/16

Trust Signal

4 signals

3/8

AI Signal

6 signals

7/12

Conversion Signal

1 signal

1/2
0

Weakest signal · fix this first

02Rebellion / Movement

“No named enemy, no named status quo, no industry pattern called out anywhere on the page.”

The page frames challenges as generic 'barriers' and 'burdens' but never names a broken status quo or takes a missionary stance against any incumbent approach.

All 19 signals, scored 0 to 2.

Narrative Clarity

8 signals

6/16
  • 01The 7-Second Test

    “Digitally-Derived Measures Using Medical Wearables" / "Decentralized Clinical Trials | Hospital-at-Home | Cardiac Monitoring”

    The vertical (clinical trials, healthcare) is visible in 7 seconds but 'who it's for' requires reading further and 'what problem it solves' is buried below the fold; a caveman would not get it instantly.

    1
  • 02Rebellion / Movementweakest

    “No named enemy, no named status quo, no industry pattern called out anywhere on the page.”

    The page frames challenges as generic 'barriers' and 'burdens' but never names a broken status quo or takes a missionary stance against any incumbent approach.

    0
  • 03Owned Language & Category

    “Digitally-Derived Measures" / "glass-box design" / "Vivalink Clinical Intelligence Platform”

    There are hints of owned framing ... 'Digitally-Derived Measures,' 'glass-box design' ... but none are defined, named as a category, or repeated consistently enough for AI to quote back as Vivalink's own term.

    1
  • 04ICP Clarity

    “Decentralized Clinical Trials | Hospital-at-Home | Cardiac Monitoring”

    Use cases are listed but buyer role, company size, and stage are never specified; a clinical operations director and a hospital CIO would both feel equally addressed ... or equally uncertain.

    1
  • 05Problem Leadership

    “Getting patients and participants to use devices correctly is one of the biggest hurdles in digital health.”

    Problems are named (adherence, data overload, system integration) but they appear mid-page under a product-led framing rather than leading the hero section with the buyer's pain.

    1
  • 06Solution Clarity

    “From Physiologic Signals to Actionable Insights, Vivalink Powers Decisions That Matter”

    A visitor can roughly understand the category (medical wearables + platform) but the one-sentence explanation of what Vivalink actually does remains vague and could describe a dozen competitors.

    1
  • 07Cost of Inaction

    “No mention of cost of inaction, failed trials, delayed decisions, patient harm, or competitive loss anywhere on the page.”

    The page never names what happens if a buyer does nothing ... no stakes, no urgency, no consequence of staying with the status quo.

    0
  • 08Promised Land

    “Translate real-world data into clinical insights that power faster, safer decisions.”

    The promised land is gestured at ('faster, safer decisions') but it is abstract and generic, not a vivid specific after-state the buyer can picture themselves living in.

    1

Trust Signal

4 signals

3/8
  • 09Proof & Evidence

    “400+ customers trust Vivalink to power clinical trials and connected care”

    One aggregate number (400+ customers) is present but there are no before/after deltas, outcome metrics, time-to-result figures, or named quantified case results anywhere.

    1
  • 10Social Proof

    “AZ-white" / "IQVIA-white" / "Stanford-white" / "Lilly" / "Novartis" / "Medpace”

    Recognizable customer logos are present (strong names) but there are zero testimonials with names, titles, or quotes, and no named case studies with attributed outcomes.

    1
  • 11Authority & Credibility

    “Clinically validated, regulatory cleared sensors ensure high integrity data you can trust.”

    Regulatory clearance is claimed but not substantiated with specific clearance names, founder credentials, published research citations, or third-party authority signals.

    1
  • 12Alternatives Acknowledged

    “No mention of alternatives, competitors, or the 'do nothing' option anywhere on the page.”

    The page never acknowledges what buyers are currently using or why Vivalink beats any alternative, leaving the differentiation case entirely unmade.

    0

AI Signal

6 signals

7/12
  • 13Customer Focus

    “Our Customers Deliver Breakthroughs Across a Wide Range of Conditions”

    There is a section gesturing at customer outcomes, but the majority of the page narrates Vivalink's platform and capabilities, not the customer's transformation journey.

    1
  • 14AI-Parmesan Index

    “No 'AI-powered' claims anywhere on the page; the company does not sprinkle AI language.”

    Vivalink makes no AI claims at all, which by the rubric earns a 2 ... there is no AI-Parmesan; the product story is grounded in wearables, physiologic data, and clinical validation.

    2
  • 15LLM Quotability

    “From signal to sensor to cloud, our glass-box design ensures unmatched provenance.”

    A few declarative sentences exist but most are vague ('decisions that matter,' 'breakthroughs') rather than clean, specific, citation-ready claims an LLM would lift verbatim.

    1
  • 16Copyright Freshness

    “No dates visible on blog posts in the scraped content; no copyright year present in the scraped markdown.”

    Blog posts are listed without visible publish dates and no copyright year appears in the content provided, removing all recency signals for AI engines.

    0
  • 17Entity Distinctiveness

    “glass-box design ensures unmatched provenance" / "Digitally-Derived Measures Using Medical Wearables”

    Some distinctive language exists (glass-box, DDMs) but the overall positioning ... wearables platform for clinical trials and remote monitoring ... is interchangeable with Biointellisense, Biobeat, or iRhythm without the logo.

    1
  • 18AI Recommendation Check

    “AI described you as: "Vivalink offers a suite of medical-grade wearable biosensors and a cloud-based data platform designed for remote patient monitoring in clinical trials and decentralized study environments.”

    AI named you when asked who it recommends for "medical wearables and remote patient monitoring platform for clinical trials and digital health", and described you accurately: "Vivalink offers a suite of medical-grade wearable biosensors and a cloud-based data platform designed for remote patient monitoring in clinical trials and decentralized study environments.". Your positioning is landing with the machines.

    2

Conversion Signal

1 signal

1/2
  • 19Path & CTA Clarity

    “Book a Demo" (primary CTA) present; "Clinical Trials Solutions" and "Healthcare Solutions" as secondary links.”

    A primary CTA exists and there are secondary navigation paths, but there is no visible numbered process or clear step sequence connecting the journey from problem to demo request.

    1

Keep the lead

AI already names Vivalink. The next edition decides if it still does.

Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Vivalink the AI recommendation, and what to write instead.

Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.

← Back to the full Healthtech index

We revamp websites that ChatGPT ignores.

See the 90-Day AI Website Rebuild →